APA Annual Meeting

NEW YORK CITY—The investigational olanzapine-samidorphan drug ALKS 3831 did not outperform olanzapine alone in reducing alcohol use in patients with schizophrenia and alcohol use disorder, but it did improve symptoms of schizophrenia, a study found.



While new treatments for depression clearly are needed, the psychiatry community needs to carefully weigh and discuss the risk/benefit ratios of the growing list of possible approaches, Alan F. Schatzberg, MD, said.

The antipsychotic medication clozapine is far too often discontinued due to side effects that can be easily managed, a trio of speakers said at the American Psychiatric Association’s annual meeting Sunday.

Samantha Saltz

Adolescents who experience cyberbullying are at increased risk for several mental health conditions, especially if they have previously been emotionally abused, researchers found.

Transcranial magnetic stimulation (TMS), particularly repetitive TMS (rTMS), shows promise for use in addiction treatment, according to a literature review presented at the American Psychiatric Association’s annual meeting.

Cognitive behavioral therapy delivered through interactive online modules reduces some depressive symptoms for up to 6 months, researchers said at the annual American Psychiatric Association meeting.